Biotech startups in New Jersey, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Claris Biotherapeutics | Jersey City | Series B | $118.0M | 2026-07-28 |
| Apprentice.io | Jersey City | Series C | $65.0M | 2023-03-20 |
| Kanvas Biosciences | Monmouth Junction | Series A | $48.0M | 2026-05-05 |
| Areteia Therapeutics | Bernardsville | Series A | $75.0M | 2024-02-13 |
| Fitnescity Health | Newark | Pre-seed | $250K | 2021-10-20 |
| Modern Meadow | Pine Brook | Series C | $130.0M | 2021-04-29 |
| Cayuga Biotech | Bridgewater | Seed | $5.0M | 2025-12-11 |
| Evergreen Theragnostics | Jersey City | Series C | $26.0M | 2024-04-16 |
8 rows of the CSV in 5 of its 18 columns.
- The 84 biotech startups in New Jersey, United States have raised $3.3B in total.
- 7 of them closed their most recent round in the last 12 months, $260.6M combined.
- The largest of those rounds is Claris Biotherapeutics' $118.0M Series B, dated July 2026.
- The most recent is Acuitive Technologies' $1.9M seed round on 17 September 2026.
- Health care is the most common other sector, with 76 companies (90%).
- 22% were founded in 2020 or later; the median founding year is 2013.
- The most common team size is 11 to 50 employees (42% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 84| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Claris Biotherapeutics | Claris Biotherapeutics develops biologic therapies for corneal diseases and ocular surface disorders. | Biotech | Jersey City | Series B | $118.0M | 2026-07-28 | $225.1M | RA Capital Management, Novo Holdings, Janus Henderson Investors +1 | 1 to 10 | 2018 |
| Kanvas Biosciences | Kanvas Biosciences maps molecular interactions to support therapeutic discovery and human health. | Biotech | Monmouth Junction | Series A | $48.0M | 2026-05-05 | $76.4M | DCVC, Pangaea Ventures, Germin8 Ventures +2 | 11 to 50 | 2020 |
| Cayuga Biotech | Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes. | Biotech | Bridgewater | Seed | $5.0M | 2025-12-11 | $8.2M | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2015 |
| Evergreen Theragnostics | Evergreen Theragnostics provides contract development and manufacturing services for radiopharmaceuticals. | Biotech | Jersey City | Series C | $26.0M | 2024-04-16 | $60.0M | LIFTT, Club degli Investitori, Petrichor Healthcare Capital Management | 11 to 50 | 2019 |
| HopeAI | HopeAI provides AI-powered clinical evidence for drug development and precision medicine. | Artificial intelligence | Princeton | Pre-seed | $1.1M | 2024-01-15 | $1.1M | Plug and Play, Taihill Venture, PKSHA Capital | 1 to 10 | 2023 |
| Apprentice.io | Apprentice.io builds manufacturing AI systems that automate workflows for teams. | Artificial intelligence | Jersey City | Series C | $65.0M | 2023-03-20 | $207.0M | Insight Partners, ICONIQ Growth, Silverton Partners +2 | 101 to 250 | 2014 |
| Fitnescity Health | Fitnescity Health builds a platform offering a large range of wellness tests. | Biotech | Newark | Pre-seed | $250K | 2021-10-20 | $250K | Techstars, Right Side Capital Management, Goodwater Capital +1 | 11 to 50 | 2020 |
| ClearPoint Learning Systems | ClearPoint Learning Systems develops web-based software learning solutions for healthcare and life sciences. | Biotech | Hoboken | Seed | $500K | 2012-07-02 | $6.9M | Edison Partners | 51 to 100 | 2001 |
Table 1. Biotech startups in New Jersey, United States: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 84.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Claris Biotherapeutics | Claris Biotherapeutics develops biologic therapies for corneal diseases and ocular surface disorders. | Biotech | Jersey City | Series B | $118.0M | 2026-07-28 | $225.1M | RA Capital Management, Novo Holdings, Janus Henderson Investors +1 | 1 to 10 | 2018 |
| 2 | Kanvas Biosciences | Kanvas Biosciences maps molecular interactions to support therapeutic discovery and human health. | Biotech | Monmouth Junction | Series A | $48.0M | 2026-05-05 | $76.4M | DCVC, Pangaea Ventures, Germin8 Ventures +2 | 11 to 50 | 2020 |
| 3 | Cayuga Biotech | Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes. | Biotech | Bridgewater | Seed | $5.0M | 2025-12-11 | $8.2M | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2015 |
Table 2. Biotech startups in New Jersey, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Janus Henderson Investors | Private equity firm | London, United Kingdom | 1 | 1% | 1 | Claris Biotherapeutics |
| 2 | RA Capital Management | Startup incubator | Boston, United States | 1 | 1% | 1 | Claris Biotherapeutics |
| 3 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 1 | 1% | 1 | Claris Biotherapeutics |
| 4 | Mass General Brigham Ventures | Corporate venture arm | Cambridge, United States | 1 | 1% | 1 | Claris Biotherapeutics |
| 5 | Insight Partners | Private equity firm | New York, United States | 1 | 1% | ||
| 6 | ICONIQ Growth | Private equity firm | San Francisco, United States | 1 | 1% | ||
| 7 | Silverton Partners | Venture capital firm | Austin, United States | 1 | 1% | ||
| 8 | Alkeon Capital | Hedge fund | New York, United States | 1 | 1% | ||
| 9 | GFR Fund | Venture capital firm | The Woodlands, United States | 1 | 1% | ||
| 10 | Germin8 Ventures | Micro VC fund | Chicago, United States | 1 | 1% | 1 | Kanvas Biosciences |
| 11 | FemHealth Ventures | Venture capital firm | New York, United States | 1 | 1% | 1 | Kanvas Biosciences |
| 12 | Pangaea Ventures | Venture capital firm | Phoenix, United States | 1 | 1% | 1 | Kanvas Biosciences |
| 13 | DCVC | Venture capital firm | Palo Alto, United States | 1 | 1% | 1 | Kanvas Biosciences |
| 14 | Ki Tua Fund | Corporate venture arm | 1 | 1% | 1 | Kanvas Biosciences | |
| 15 | Google Ventures | Corporate venture arm | San Francisco, United States | 1 | 1% |
Table 3. Biotech startups in New Jersey, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 76 | 90% | $2.9B |
| Software | 13 | 15% | $556.6M |
| Artificial intelligence | 6 | 7% | $365.4M |
| Education | 3 | 4% | $29.2M |
| Commerce | 1 | 1% | $20K |
| Hardware | 1 | 1% | $43.3M |
| Energy | 1 | 1% |
Table 4. Biotech startups in New Jersey, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in New Jersey, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Princeton | 17 | 20% |
| Bridgewater | 6 | 7% |
| Jersey City | 5 | 6% |
| Monmouth Junction | 4 | 5% |
| Newark | 4 | 5% |
| North Brunswick | 3 | 4% |
| Bernardsville | 2 | 2% |
| Mount Laurel | 2 | 2% |
| Somerset | 2 | 2% |
| Basking Ridge | 2 | 2% |
| East Brunswick | 2 | 2% |
| Warren | 2 | 2% |
Table 6. Biotech startups in New Jersey, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 14% | $1.9M |
| July 2026 | 3 | 43% | $120.7M |
| May 2026 | 1 | 14% | $48.0M |
| February 2026 | 1 | 14% | $85.0M |
| December 2025 | 1 | 14% | $5.0M |
Table 7. Biotech startups in New Jersey, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 6 | 7% | $255.6M |
| 2025 | 4 | 5% | $22.0M |
| 2024 | 8 | 10% | $135.4M |
| 2023 | 7 | 8% | $315.3M |
| 2022 | 4 | 5% | $82.7M |
| 2021 | 5 | 6% | $134.5M |
Table 8. Biotech startups in New Jersey, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 4 | 5% |
| 2020 to 2022 | 14 | 17% |
| 2015 to 2019 | 16 | 20% |
| 2010 to 2014 | 13 | 16% |
| Before 2010 | 35 | 43% |
Table 9. Biotech startups in New Jersey, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 29 | 37% |
| 11 to 50 | 33 | 42% |
| 51 to 100 | 9 | 11% |
| 101 to 250 | 4 | 5% |
| 251 to 500 | 2 | 3% |
| 501 to 1,000 | 2 | 3% |
Table 10. Biotech startups in New Jersey, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in New Jersey, United States. On 16 November 2026 that is 84 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 84 rows: 11 have no round amount, 0 no city and 13 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in New Jersey, United States are on the list?
- 84, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 84 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.